EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Corporate Action Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory…